🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones ◆ Using LLMs Safely in Pharma: The Employee Guide to Risk Mitigation, Ethics, and GxP Compliance ◆ US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position ◆ US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition ◆ ChatGPT Maker OpenAI Selects Dublin Docklands for New European HQ Expansion ◆ After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA ◆ AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones ◆ Using LLMs Safely in Pharma: The Employee Guide to Risk Mitigation, Ethics, and GxP Compliance ◆ US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position ◆ US Biopharma Group Pfanstiehl Acquires Nestlé’s Former Askeaton Infant Formula Site in Landmark Mid-West Industrial Transition ◆ ChatGPT Maker OpenAI Selects Dublin Docklands for New European HQ Expansion ◆ After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA ◆

Pharma Glossary

The definitive, structured ontology of pharmaceutical, biotechnology, and medical device acronyms, regulations, and terminology.

All Terms Biotechnology Clinical Trials Manufacturing Pharmacovigilance Quality Assurance Regulatory Affairs
A C E F H I M O P S T V
A
Annex 1 Regulatory Affairs
The section of the EU Good Manufacturing Practice (GMP) guidelines governing the manufacture of sterile medicinal products.
Local Context (Ireland/EU): A major revision of Annex 1 came into operation in August 2023, introducing stricter requirements for contamination control strategy (CCS).
ASMF Regulatory Affairs
Active Substance Master File.
Local Context (Ireland/EU): A submission to regulatory authorities providing confidential detailed information about the manufacture and control of an active substance (API).
C
CEP Regulatory Affairs
Certificate of Suitability.
Local Context (Ireland/EU): A certificate issued by the EDQM confirming that a substance complies with the monographs of the European Pharmacopoeia.
CTA Regulatory Affairs
Clinical Trial Application.
Local Context (Ireland/EU): The formal application requesting approval to conduct a clinical trial in the EU, now submitted via the Clinical Trials Information System (CTIS).
CTD Regulatory Affairs
Common Technical Document.
Local Context (Ireland/EU): The internationally agreed format for organizing applications (Modules 1-5) submitted to regulatory authorities.
E
eCTD Regulatory Affairs
Electronic Common Technical Document.
Local Context (Ireland/EU): The electronic version of the CTD format, mandatory for all EMA submissions and most national submissions in Europe.
EMA Regulatory Affairs
European Medicines Agency.
Local Context (Ireland/EU): The EU body responsible for the scientific evaluation, supervision, and safety monitoring of medicines. Relocated from London to Amsterdam in 2019.
Embargo Regulatory Affairs
A request or agreement that information provided in a press release should not be published by the media until a designated date and time.
Local Context (Ireland/EU): Commonly used when distributing clinical trial phase results or regulatory approval announcements in advance to trusted journalists.
F
FDA Regulatory Affairs
Food and Drug Administration (United States).
Local Context (Ireland/EU): The US federal agency regulating food, drugs, and medical devices. HPRA-regulated Irish manufacturing sites exporting to the US are regularly audited by the FDA.
H
HPRA Regulatory Affairs
Health Products Regulatory Authority.
Local Context (Ireland/EU): The state agency responsible for regulating medicines, medical devices, and other health products in Ireland. Formerly known as the Irish Medicines Board (IMB).
I
ICH Regulatory Affairs
International Council for Harmonisation.
Local Context (Ireland/EU): The global body bringing together regulators and industry to standardize technical requirements for pharmaceutical development (e.g., Q8, Q9, Q10).
IMP Regulatory Affairs
Investigational Medicinal Product.
Local Context (Ireland/EU): An active ingredient or placebo being tested or used as a reference in a clinical trial. IMPs must be manufactured under strict EU GMP Volume 4 requirements.
M
MAA Regulatory Affairs
Marketing Authorization Application.
Local Context (Ireland/EU): The application submitted to the EMA or national authorities (like the HPRA) to market a drug within the European Economic Area (EEA).
Media Relations Regulatory Affairs
The process of coordinating and building relationships with journalists, editors, and industry publications to secure organic media coverage.
Local Context (Ireland/EU): Irish biotechs build media relations with trade publications like FierceBiotech and regional platforms like Priya Life Science to attract venture capital.
O
Orphan Drug Regulatory Affairs
A medicine developed to treat rare medical conditions that would not be profitable to produce without government assistance or market exclusivity.
Local Context (Ireland/EU): In the EU, orphan designation grants 10 years of market exclusivity upon approval to encourage rare disease R&D.
P
PIL Regulatory Affairs
Package Leaflet.
Local Context (Ireland/EU): The leaflet included in the medicine box containing information for patients. It must align exactly with the approved SmPC in local languages.
PIP Regulatory Affairs
Paediatric Investigation Plan.
Local Context (Ireland/EU): A research and development plan to ensure that necessary data on the safety and efficacy of a medicine in children are gathered.
Public Relations Regulatory Affairs
The strategic practice of managing and disseminating information from an individual or organization to the public to construct a favorable reputation.
Local Context (Ireland/EU): For life science firms in Ireland, PR campaigns are regulated by HPRA codes to avoid off-label promotional violations.
S
Scientific Advice Regulatory Affairs
Formal meetings where developers discuss clinical, non-clinical, or quality testing plans with regulators before submitting marketing applications.
Local Context (Ireland/EU): HPRA offers Scientific Advice to Irish life science startups and academic research teams to streamline development.
SmPC Regulatory Affairs
Summary of Product Characteristics.
Local Context (Ireland/EU): The official document approved by regulators outlining how a medicine should be used safely, forming the basis for the Package Leaflet (PIL).
T
Thought Leadership Regulatory Affairs
The practice of expressing authoritative, original ideas and commentary in a specialized field to establish expertise and credibility.
Local Context (Ireland/EU): Highly utilized by Quality Assurance and Regulatory directors on LinkedIn to build site and personal authority.
V
Variations Regulatory Affairs
Changes made to the parameters of an approved marketing authorization after a medicine is on the market.
Local Context (Ireland/EU): Categorized into Type IA (minor, do not require approval), Type IB (minor, require validation), and Type II (major scientific assessment required).